[44] A 2016 Cochrane review found it unclear if the use of heated tobacco products (HTPs) would "substantially alter the risk of harm" over traditional cigarettes.
[49] With an assorted range of electronic cigarettes devices available in the UK, it is unclear if HTPs offer any favorable benefit as a plausible harm reduction product.
[3][51] Other traditional cigarette emission substances such as tar, nicotine, carbonyl compounds (including acetaldehyde, acrolein, and formaldehyde), and nitrosamines are also found in HTPs.
[41] Physiological changes in response to heated tobacco emissions, such as multiple organ system inflammation, energy metabolism, and carcinogenesis, have not been well characterised due to limited research in this area, especially in animal models.
[36] A 2018 in vitro study suggested a less harmful pathophysiological response in human organotypic oral epithelial cultures when exposed to such emissions.
[36] A 2016 animal study showed that heated tobacco emissions did not increase surfactant lipids and proteins, inflammatory eicosanoids and their metabolic enzymes, and several ceramide classes in HTP-exposed mice when compared with their counterparts that were exposed to cigarette smoke.
[3] In 2017, the Committee on Toxicity noted that "[c]ommittees were particularly concerned for young people, who do not smoke, starting to use these products, due to the potential for longer exposure over the remainder of their lives compared to adults and to possible differences in sensitivity.
[48] According to four epidemiological papers, 10–45 per cent of non-smokers use these products, and show the effectiveness of the marketing of the tobacco industry[improper synthesis?
While Philip Morris International stated it only retrieves the data when the product is not working properly, Gregory Connolly, a professor at Northeastern University who has studied IQOS, said that tobacco companies like PMI would have a "mega database" of Americans' smoking habits, and possibly "reprogram the current puffing delivery pattern of the IQOS to one that may be more reinforcing and with a higher addiction potential".
[41] Nicotine is harmful to the infant and the growing adolescent brain,[3] is metabolised much faster while a woman is pregnant, easily passes through the placental barrier, and collects in breast milk.
Animal research in regards to maternal nicotine exposure on rats showed a direct adverse impact on pancreas development by reducing endocrine pancreatic islet size and number, which was accompanied by a decrease in gene expression of specific transcription factors and blood glucose regulating hormones such as insulin and glucagon.
[66] The burning process, substances emitted and their levels vary at different temperatures: distillation—the process during which nicotine and aromas are transferred from tobacco to smoke—occurs below 300 °C; pyrolysis occurs around 300 °C–700 °C and involves the decomposition of biopolymers, proteins, and other organic materials and generates the majority of substances emitted in smoke; and combustion occurs above 750 °C and results in the generation of carbon dioxide, carbon monoxide, and water.
[17] Since the constituents of HeatSticks may differ from combustible cigarettes, including flavourants and additives, it is plausible that the IQOS aerosol may contain substances not found in tobacco smoke.
[11] For this purpose, tobacco sticks are placed in a corresponding heater and heated to about 250–350 °C (around 500 °F),[11][35] which result in nicotine-containing emissions that are inhaled via a mouthpiece with a filter segment.
[11] HTPs are hybrids between electronic and conventional cigarettes: they are equipped with a device that heats the product without reaching combustion to generate aerosol, while using "real" tobacco instead of nicotine-containing liquids.
[70] It was shaped like a traditional cigarette, and required combustion to move the smoldered charcoal past processed tobacco containing more than 50 percent glycerin to create an aerosol.
[20][80] An attempt was made in 2007 by Kenneth Podraza, the Vice President of Research and Development at Philip Morris in the US at the time, to get the Surgeon General of the United States to endorse it.
Caputi suggests that the ubiquity of e-cigarettes and the growing dissatisfaction with not providing a "throat-hit"[clarification needed] may present an opportunity for HTPs.
HTPs are designed to be similar to their combustible counterparts by replicating the oral inhalation and exhalation, taste, rapid systemic delivery of nicotine, hand-to-mouth feel and throat hit sensations (depending on the temperature) when smoking traditional cigarettes.
[89] In 2016, British American Tobacco launched a battery-powered heated product called glo in Japan before selling it in South Korea,[90] Switzerland, Russia,[12] and Ukraine.
[92] Bonnie Herzog, a senior analyst at Wells Fargo Securities, stated that the proposed acquisition of R. J. Reynolds by British American Tobacco in 2016 would let them catch up with the competition.
[17] IQOS (/ˈaɪkoʊs/ EYE-kohs) is a non-combustible "reduced risk" smoking alternative that was introduced in June 2014 and is marketed by Philip Morris International (PMI) under the Marlboro and Parliament brands.
[111] In December 2017, Reuters published documents and testimonies of former employees detailing irregularities in the clinical trials conducted by PMI for the approval of the IQOS product by the US FDA.
[123] The Pax 2 vaporizer uses loose plant material such as tobacco or cannabis and remains cool to the touch while the oven heats to one of four temperatures (up to 455 °F).
[134] In September 2020, Yunnan Xike Science & Technology Co., Ltd. launched Cigoo;[135] according to the company, it is a heated herbal product which releases nicotine and aroma aerosol at 300 °C, similar to mainstream HTPs.
Moreover, forecasts relying on the historical trend suggest heat-not-burn searches would increase an additional 32% (95%CI: -4 to 79) during 2018, compared to current estimates for 2017 (January–September), with further growth expected.
Some media accounts that announced product launches state that HTPs reduce the levels of harmful tobacco components by 90–95% compared to traditional cigarettes, while others emphasise the lack of odor or visible emissions as part of marketing campaigns; as of April 2018[update], there is no evidence to confirm the former claim.
[151] In the United States, these products fall under the jurisdiction of the Food and Drug Administration (FDA) as amended by the Family Smoking Prevention and Tobacco Control Act of 2016.
"[49] In 2017, Mitchell H. Katz, director of the Los Angeles County Health Agency, wrote: "There is concern that heat-not-burn tobacco will skirt local ordinances that prevent smoking in public areas.
Moreover, the enforcement of various tobacco control regulations is only minimally adopted for HTPs in Italy: health warnings are required to cover only 30% of the heated tobacco product packaging (instead of 65% for traditional cigarettes), without pictorial images; comprehensive smoke-free regulations prohibiting smoking in all public places and workplaces do not apply to HTPs; and advertising and promotions are not banned for them.